{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T09:54:24Z","timestamp":1753869264745,"version":"3.41.2"},"reference-count":49,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Health Science Reports"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background and Aims<\/jats:title><jats:p>Monkeypox (Mpox) has become a concern worldwide after spreading into nonendemic countries. The World Health Organization (WHO) has declared this a public health emergency of international concern and recommended to get vaccinated first who are at the highest risk. Risk perception and subjective norms can influence the decision of vaccine uptake. Therefore, we intended to perform a cross\u2010sectional study on the male population in our country to assess their risk perception and subjective norms on Mpox.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We measured participants' risk perception and subjective norms using Google form. Demographic profile of participants was obtained using a structured questionnaire. We performed a <jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup> test to compare the levels of risk perception and subjective norm perception and multiple logistic regression analysis to determine the association between the study parameters and the sociodemographic profile of the participants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the participants, 93 (23.72%), 288 (73.47%), and 11 (2.81%) had high, medium, and low\u2010risk perceptions, respectively. For subjective norms, we observed 288 (58.16%) participants had a medium, 117 (29.85%) had high, and 47 (11.99%) had low levels of subjective norms, respectively. Most participants possessed medium risk perception (73.47%) and subjective norms (58.16%). Moreover, we observed that moderate risk perception was prevalent in people with body mass index (BMI) level between 18.5 and 25 (73.3%), married (63.5%), low economic background (94.1%), living with a family (77.1%), smokers (68.4%), heterosexuals (99%), people with no\/little impact of coronavirus disease 2019 (Covid\u201019) on life (91%). Proportions of people with moderate subjective norms BMI level of 18.5\u201325 (73.2%), married (60.5%), low economic status (93.9%), rural (58.8%), living with family (77.2%), nonsmokers (71.1%), and people with no\/little impact of Covid\u201019 in their lives (91.2%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The majority of participants perceived medium risk perception and subjective norms related to Mpox. Furthermore, we observed a significant association between the study parameters and the sociodemographic characteristics of our study participants. We recommend that further longitudinal studies to yield more accurate results.<\/jats:p><\/jats:sec>","DOI":"10.1002\/hsr2.1352","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T11:51:18Z","timestamp":1686829878000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of risk perception and subjective norms related to Mpox (monkeypox) among adult males in Bangladesh: A cross\u2010sectional study"],"prefix":"10.1002","volume":"6","author":[{"family":"Nazmunnahar","sequence":"first","affiliation":[{"name":"Department of Sociology, Eden Women's College National University Bangladesh Gazipur Bangladesh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Anamul","family":"Haque","sequence":"additional","affiliation":[{"name":"Department of Pharmacy University of Asia Pacific Dhaka Bangladesh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bulbul","family":"Ahamed","sequence":"additional","affiliation":[{"name":"Department of Pharmacy University of Asia Pacific Dhaka Bangladesh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md.","family":"Tanbir","sequence":"additional","affiliation":[{"name":"Department of Pharmacy University of Asia Pacific Dhaka Bangladesh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhana Islam","family":"Suhee","sequence":"additional","affiliation":[{"name":"Department of Pharmacy University of Asia Pacific Dhaka Bangladesh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2820-3144","authenticated-orcid":false,"given":"Md. Rabiul","family":"Islam","sequence":"additional","affiliation":[{"name":"Department of Pharmacy University of Asia Pacific Dhaka Bangladesh"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,6,15]]},"reference":[{"key":"e_1_2_11_2_1","unstructured":"World Health Organization. Monkeypox.2023. Accessed on November 18 2022.https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/monkeypox"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac310"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/2632010X221131660"},{"key":"e_1_2_11_5_1","unstructured":"World Health Organization.2022. Vaccines and immunization for monkeypox: Interim guidance. Accessed on November 18 2022.https:\/\/www.who.int\/publications\/i\/item\/WHO-MPX-Immunization"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2018.00241"},{"key":"e_1_2_11_7_1","unstructured":"Wikipedia. Monkeypox.\u00a02023. Accessed on November 18 2022.https:\/\/en.wikipedia.org\/wiki\/Monkeypox#cite_note-39"},{"key":"e_1_2_11_8_1","unstructured":"Centers for Disease Control and Prevention.2022. Monkeypox Outbreak Global Map.\u00a0Accessed on November 18 2022.https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/response\/2022\/world-map.html"},{"issue":"1","key":"e_1_2_11_9_1","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.1030","article-title":"Decreasing trend of monkeypox cases in Europe and merica shows hope for the world: evidence from the latest epidemiological data","volume":"6","author":"Khan MR","year":"2022","journal-title":"Health Sci Rep"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27931"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2022.102386"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.24.2200448"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11080904"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11111285"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.997637"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/20477724.2020.1743037"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2022.08.015"},{"key":"e_1_2_11_18_1","unstructured":"NSW Health. MPOX (Monkeypox).2023. Accessed on May 7 2023.https:\/\/www.health.nsw.gov.au\/Infectious\/factsheets\/Pages\/monkeypox.aspx"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-08-097086-8.14138-8"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2022.11.004"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0278622"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268063"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1177\/1529100618760521"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10030427"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.3758\/s13415-021-00947-0"},{"issue":"1","key":"e_1_2_11_26_1","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.1069","article-title":"Monkeypox and sex: sexual orientations and encounters are key factors to consider","volume":"6","author":"Islam MR","year":"2022","journal-title":"Health Sci Reports"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-022-01421-8"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2022.102426"},{"key":"e_1_2_11_29_1","article-title":"Assessment of knowledge on human monkeypox virus among general population in Bangladesh: a nationwide cross\u2010sectional study","author":"Nath SD","year":"2022","journal-title":"Medrxiv"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed7070135"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102505"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-015-0010-5"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbspro.2015.06.252"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010565"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_1841_21"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0273687"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/175694"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.1281"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1177\/2632010X231161222"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.884"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1177\/20587384211065628"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1177\/00368504211058562"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S276771"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-020-00671-y"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1177\/20503121211073014"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.00381"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.09.021"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100495"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10122026"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0286322"}],"container-title":["Health Science Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hsr2.1352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T22:21:43Z","timestamp":1692483703000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hsr2.1352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1002\/hsr2.1352"],"URL":"https:\/\/doi.org\/10.1002\/hsr2.1352","archive":["Portico"],"relation":{},"ISSN":["2398-8835","2398-8835"],"issn-type":[{"type":"print","value":"2398-8835"},{"type":"electronic","value":"2398-8835"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"2023-02-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e1352"}}